[First-line monotherapy with boostered protease inhibitor. Effectively reduce viral load with only one drug?].
Theobald
T
T
Praxis Dres. Jäger/ Jägel-Guedes, München. info@jajaprax.de
Jäger
H
H
D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D024882:Drug Resistance, Viral; D004357:Drug Synergism; D042241:Early Diagnosis; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006679:HIV Seropositivity / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D019562:Viral Load
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir